Amkay Products

SMEBSE: 544169
Compare with peers
₹ 53.00 0 (0%)27 Oct, 09:27 am IST
Market cap
₹ 44 Cr.
P/E
22.5x
P/B
1.82x
52-week range
43 – 81.99
ROE
8%
ROCE
12%
Dividend yield
0%
Debt / equity
0.15
Sector
Healthcare Equipment & Supplies
Industry
Medical Equipment & Supplies
Listed on
BSE SME

About

Amkay Products Limited is engaged in the business of manufacturing, assembling and marketing a comprehensive portfolio of medical devices, disposables and other healthcare products. The Company’s product portfolio comprises more than 30 products, including respiratory disease related medical devices, surgical disposables, home healthcare products and other healthcare products. The Company’s products include nebulizers, blood pressure monitors, air beds, adult diapers, hot water bags, face masks, alcohol swabs, blood lancet needles, HIV kits, bio bags, apron gowns and many products to various hospitals, institutions, government bodies, pharmaceutical companies, distributors, and dealers spread across India. It also provides Ambu bag, pocket fetal dropper, body massager, suction machine, knee-length shoe cover and others. In addition, it is also engaged in branding and marketing of some products like diapers, plastic gloves, and suction machines.

Quick check

The five things to look at first. Open one for more.

Amkay Products against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)22.5 against a typical 28.7: cheaper than most peers (1st = cheapest).11th of 25
  • Sales growth+14% against a typical +21.5% from a year earlier.13th of 18
  • Profit growth−74.4% against a typical +13.4% from a year earlier.14th of 16
  • Share price, 3 months+10.4% against a typical −7.9%.4th of 23
  • Size₹ 43.6 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).19th of 24

Share price

1Y change +20.7%
Volume (shares)Price (₹)
Close price

Financials

Standalone figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales141718212319
Expenses131515192018
Operating Profit222231
OPM %12.5%9.2%13.4%8.5%12.9%4.6%
Other Income011100
Interest000000
Depreciation000000
Profit before tax223231
Tax %26.6%23.3%30%10.6%26.9%33.3%
Net Profit112220
EPS in Rs2.042.092.111.742.280.39

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
—
5 Years
1%
3 Years
15%
TTM
9%
Compounded Profit Growth
10 Years
—
5 Years
−7%
3 Years
16%
TTM
0%
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
TTM
—
Return on Equity
10 Years
—
5 Years
14%
3 Years
12%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
73.44%
0 pts in a year
FIIs
0%
0 pts in a year
DIIs
0%
0 pts in a year
Public
26.56%
−0.01 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 22.5xEPS (12 months) ₹ 2.36Median P/E 17.8x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Amkay Products₹ 53.00₹ 44 Cr.22.5x1.8x8%—
Lenskart Solutions₹ 627.55₹ 1,08,959 Cr.232.9x13.8x—6.9%
Poly Medicure₹ 1,446.80₹ 14,582 Cr.53.5x5.6x—15.7%
Laxmi Dental₹ 171.25₹ 946 Cr.32.3x4.5x—10%
Hemant Surgical Industries₹ 570.00₹ 829 Cr.31.3x4.4x18.1%7.9%
Mallcom (India)₹ 909.00₹ 567 Cr.20.3x1.9x—5.1%

Management

Kashyap Pravin Mody
Managing Director, Executive Chairman of the Board
Hemanshu Kantilal Batavia
Chief Financial Officer, Whole Time Director
Krishna Rathi
Compliance Officer, Company Secretary

Prices are delayed and for information only. Nothing on this page is investment advice.